Cargando…
Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus
OBJECTIVES: To assess the achievability and effect of attaining low disease activity (LDA) or remission in childhood-onset SLE (cSLE). METHODS: Attainment of three adult-SLE derived definitions of LDA (LLDAS, LA, Toronto-LDA), and four definitions of remission (clinical-SLEDAI-defined remission on/o...
Autores principales: | Smith, Eve M D, Tharmaratnam, Kukatharmini, Al-Abadi, Eslam, Armon, Kate, Bailey, Kathryn, Brennan, Mary, Ciurtin, Coziana, Gardner-Medwin, Janet, Haslam, Kirsty E, Hawley, Daniel, Leahy, Alice, Leone, Valentina, Malik, Gulshan, McLaren, Zoe, Pilkington, Clarissa, Ramanan, Athimalaipet V, Rangaraj, Satyapal, Ratcliffe, Annie, Riley, Philip, Sen, Ethan, Sridhar, Arani, Wilkinson, Nick, Hedrich, Christian M, Jorgensen, Andrea, Beresford, Michael W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348762/ https://www.ncbi.nlm.nih.gov/pubmed/34894234 http://dx.doi.org/10.1093/rheumatology/keab915 |
Ejemplares similares
-
Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?—observations from the UK JSLE Cohort Study
por: Smith, Eve M D, et al.
Publicado: (2021) -
Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK
por: Massias, Joseph S, et al.
Publicado: (2021) -
Neuropsychiatric involvement in juvenile-onset systemic lupus
erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus
cohort study
por: Giani, Teresa, et al.
Publicado: (2021) -
Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE
por: Charras, Amandine, et al.
Publicado: (2022) -
‘It is good to have a target in mind’: qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus
por: Smith, Eve M D, et al.
Publicado: (2021)